ERBB2 and breast carcinoma: However, normal tissue has a low complement of HER2 membrane protein, whereas HER2-positive breast cancers can have an increase up to 40–100-fold in HER2 protein resulting in 2 million receptors expressed at the tumor cell surface [29, 30].